• Home
  • Risk of progression following a negative biopsy in prostate cancer active surveillance.

Risk of progression following a negative biopsy in prostate cancer active surveillance.

Author List
Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
Publication
Prostate cancer and prostatic diseases
Publication ID (Profile URL)
https://researcherprofiles.org/profile/366101778
Publication Year
2022
PubMed ID
36008540
Publication Title
Beckmann K, Santaolalla A, Sugimoto M, Carroll P, Rubio J, Villers A, Bjartell A, Morgan T, Dasgupta P, Van Hemelrijck M, Elhage O, Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Risk of progression following a negative biopsy in prostate cancer active surveillance. Prostate Cancer Prostatic Dis. 2023 06; 26(2):403-409.